Ambra Capital
Also known as CapHorn Invest, CapHorn, Cap Horn VC, Anaxago Capital
Paris AMF-authorised manager (ex Anaxago Capital), regrouped with VC brand CapHorn Invest in Dec 2025; €750M across real-estate debt and equity, hospitality, venture capital and PE fund-of-funds.
- HEADQUARTERS
- Paris, France
- FOUNDED
- —
- AUM
- €750M (2025)
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 6 people
Focus
- STAGES
- SeedSeries ASeries BGrowth
- ASSET MIX
- Venture capitalPrivate equityFunds (as LP)Real estatePrivate credit
- GEOGRAPHY
- FranceEurope
Overview
Ambra Capital is the new name, announced in December 2025, of Anaxago Capital, the AMF-authorised management company of the Anaxago group, which regrouped its activities and those of its venture capital brand CapHorn Invest under one identity. It reported €750M under management across funds and clubs and 20 investment professionals, with strategies in real-estate private debt and development, hospitality, private-equity fund-of-funds (AxClimat I) and venture capital. The venture strategy, inherited from CapHorn (founded in 2011), co-invests €1–5M from seed to Series B in AI/data, climate and health technology alongside lead funds; past CapHorn holdings include Ledger, Wandercraft and Robocath.
Investment thesis
Venture capital: technology companies from seed to Series B in AI, data and SaaS (incl. cybersecurity and infrastructure), climate and impact tech (energy, health, education) and manufacturing 4.0; average ticket €1–5M, 4–8 year horizon, co-investing with established funds. CapHorn’s site lists climatetech, healthtech and enterprise tech, tickets €1–20M from seed to IPO.
PORTFOLIO (22)
- WandercraftNOTABLEHealthTech · since 2019
- LedgerNOTABLEFintech · since 2021
- HealthTech
- PhagosBiotech & Life Sciences · since 2024
- Software & SaaS · since 2024
- Climate & Energy
- HealthTech
- HealthTech
- HealthTech
- Biotech & Life Sciences
- Biotech & Life Sciences
- Climate & Energy
- Food & Agriculture
- Food & Agriculture
- Software & SaaS
- Software & SaaS
- Fintech · Exited
- Software & SaaS · Exited
- Software & SaaS · Exited
- Software & SaaS · Exited
- Software & SaaS · Exited
- DathenaSoftware & SaaS · Exited (2022)
People
- Président · source
- Bruno BlancDirecteur général adjoint · source
- Pierre LainéDirecteur Portfolio VC · source
- Guillaume RegertDirecteur Investissement & Asset Management Immobilier · source
- Vincent LachêneDirecteur du Développement · source
- Guillaume DupontFounder of CapHorn (2011); Venture Partner · source
Links
Frequently asked questions
Ambra Capital is a private equity fund based in Paris, France.
Yes. Ambra Capital invests its own capital in private companies. It also commits capital to third-party funds as an LP.
Ambra Capital invests at Seed, Series A, Series B and Growth stages in HealthTech, Climate & Energy, Software & SaaS, Artificial Intelligence and Real Estate & PropTech.
Ambra Capital's stated ticket size is €1M–€5M.
Key people at Ambra Capital include Joachim Dupont (Président), Bruno Blanc (Directeur général adjoint), Pierre Lainé (Directeur Portfolio VC) and Guillaume Regert (Directeur Investissement & Asset Management Immobilier).
Ambra Capital's investments include Wandercraft, Ledger, Therapixel, Phagos, Naboo, EODev, Tilak Healthcare and Robocath, among others.
The most recent publicly reported investment by Ambra Capital is Therapixel (Series B+ co-investment (€3.4M “levés”, convertible bonds)), announced in Dec 2025.
Yes. Ambra Capital manages capital from outside investors.